(Q44478511)

3 December 2017

title

Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity (English)

1 reference

3 December 2017

1 reference

1 reference

Penny J Jensen

1

1 reference

3 December 2017

Benedict J Alter

series ordinal

2

1 reference

3 December 2017

Karen L O'Malley

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Journal of Neurochemistry

3 December 2017

published in

1 reference

3 December 2017

volume

86

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

196-209

1 reference

alpha-synuclein promotes mitochondrial deficit and oxidative stress

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01835.X

dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01835.X

Physiology and pathophysiology of alpha-synuclein. Cell culture and transgenic animal models based on a Parkinson's disease-associated protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01835.X

Effects of Dibutyryl Cyclic AMP and Retinoic Acid on the Differentiation of Dopamine Neurons: Prevention of Cell Death by Dibutyryl Cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2003.01835.X

10.1046/J.1471-4159.2003.01835.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference